BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15893848)

  • 1. Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying.
    Breyer F; Felder S
    Health Policy; 2006 Jan; 75(2):178-86. PubMed ID: 15893848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care costs in the last year of life--the Dutch experience.
    Polder JJ; Barendregt JJ; van Oers H
    Soc Sci Med; 2006 Oct; 63(7):1720-31. PubMed ID: 16781037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs.
    Seshamani M; Gray A
    Age Ageing; 2004 Nov; 33(6):556-61. PubMed ID: 15308460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health care expenditures and the aging population].
    Felder S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):614-21. PubMed ID: 22526849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of population ageing on future Danish drug expenditure.
    Kildemoes HW; Christiansen T; Gyrd-Hansen D; Kristiansen IS; Andersen M
    Health Policy; 2006 Feb; 75(3):298-311. PubMed ID: 16399170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of demographic changes on health care expenditure in Germany: an analysis considering the expenditures of decedents].
    Gandjour A; Ihle P; Schubert I
    Gesundheitswesen; 2008 Feb; 70(2):77-80. PubMed ID: 18348096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does prevention save costs? Considering deferral of the expensive last year of life.
    Gandjour A; Lauterbach KW
    J Health Econ; 2005 Jul; 24(4):715-24. PubMed ID: 15960993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reimbursed health expenditures during the last year of life, in France, in the year 2008].
    Ricci P; Mezzarobba M; Blotière PO; Polton D
    Rev Epidemiol Sante Publique; 2013 Feb; 61(1):29-36. PubMed ID: 23318018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical expenditures as a correlate of population health in industrialized nations.
    Liu L; Cline RR; Schondelmeyer SW; Schommer JC
    Ann Pharmacother; 2008 Mar; 42(3):368-74. PubMed ID: 18272699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007.
    Köster I; Huppertz E; Hauner H; Schubert I
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):377-85. PubMed ID: 21264804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging diseases--do they prevent preventive health care from saving costs?
    Gandjour A
    Health Econ; 2009 Mar; 18(3):355-62. PubMed ID: 18833543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure.
    Blakely T; Atkinson J; Kvizhinadze G; Nghiem N; McLeod H; Wilson N
    N Z Med J; 2014 May; 127(1393):12-25. PubMed ID: 24816953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The high cost of dying" revisited.
    Scitovsky AA
    Milbank Q; 1994; 72(4):561-91. PubMed ID: 7997219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and quality of life of multiple sclerosis in Germany.
    Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Medicare payments in the last year of life.
    Lubitz JD; Riley GF
    N Engl J Med; 1993 Apr; 328(15):1092-6. PubMed ID: 8455667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projecting health-care expenditure for Switzerland: further evidence against the 'red-herring' hypothesis.
    Colombier C; Weber W
    Int J Health Plann Manage; 2011; 26(3):246-63. PubMed ID: 20939027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.